TNF and neoplasm: Thus, the production of TNFα by tumor or other cells in the microenvironment may, therefore, be an indicator and requirement for responsiveness to IAP inhibitor therapy, which relies on TNFα activation for the induction of apoptosis, necroptosis, and DNA-damage-associated cell death.